Back

Usefulness of a simple clinical score in identifying increased risk of transthyretin amyloid cardiomyopathy in older patients with unexplained hypertrophic cardiomyopathy

11 May 2024 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 8 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francesco Cappelli

Careggi University Hospital (AOUC), Florence (Italy)

7 More presentations in this session

Presentation thumbnail
Soluble urokinase-type plasminogen activator surface receptor is associated with kidney disease in heart failure patients
Mrs A. Dieden (Malmoe, SE)
Abstract Slides Video
Presentation thumbnail
Study design, baseline characteristics, and in-hospital outcomes of acute heart failure in Korea: initial report from the nationwide Korean Heart Failure III Registry
Professor H. Cho (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Incidence of 1-year mortality, heart failure admissions and decompensation in patients with heart failure followed in HF units in Spain. Differences according to type of units.
Doctor R. Gonzalez-Manzanares (Cordoba, ES)
Abstract Slides Video
Presentation thumbnail
Bendopnea prevalence and prognostic value in older patients with heart failure: FRAGILE-HF and SONIC-HF post hoc analysis
Doctor T. Nakade (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Navigating heart failure: unveiling sex disparities in guideline-directed medical therapy combinations
Assistant Professor I. Colluoglu (Izmir, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 8

The Event

Event poster

Heart Failure 2024

11 May 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Validation of two clinical scores for transthyretin amyloid cardiomyopathy in a mediterranean cohort of patients at risk
thumbnail
Congress Presentation
Development of TTRACK study diagnostic scores to identify elevated risk of transthyretin amyloid cardiomyopathy in older patients with unexplained hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources